Cargando…

High Expression of NLRC5 Is Associated with Prognosis of Gastric Cancer

OBJECTIVE: To explore the relationships of NLRC5 with clinicopathological characteristics and prognosis of gastric cancer patients. METHODS: A total of 97 gastric cancer patients undergoing radical gastrectomy were enrolled. All patients were diagnosed by immunohistochemical staining. The relationsh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yuemei, Zhang, Min, Zheng, Xinhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2018
Materias:	Regular Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6227742/ https://www.ncbi.nlm.nih.gov/pubmed/30426081 http://dx.doi.org/10.1515/med-2018-0066

Ejemplares similares

Loss of Annexin A10 Expression Is Associated with Poor Prognosis in Early Gastric Cancer
por: Ishikawa, Akira, et al.
Publicado: (2020)

NLRC4 Gene Single Nucleotide Polymorphisms Are Associated with the Prognosis of Hemophagocytic Lymphohistiocytosis
por: Li, Yan, et al.
Publicado: (2021)

NLRP3, NLRC4 and NLRC5 Gene Polymorphisms Associate with Susceptibility of Pulmonary Aspergillosis in Non-Neutropenic Patients
por: Zhong, Jinjin, et al.
Publicado: (2022)

NLRC5, at the Heart of Antigen Presentation
por: Neerincx, Andreas, et al.
Publicado: (2013)

CD5 and CD43 Expression are Associate with Poor Prognosis in DLBCL Patients
por: Huang, Hui, et al.
Publicado: (2018)

Clinical and Molecular Correlates of NLRC5 Expression in Patients With Melanoma
por: Lv, Lei, et al.
Publicado: (2021)

Upregulation of the NLRC4 inflammasome contributes to poor prognosis in glioma patients
por: Lim, Jaejoon, et al.
Publicado: (2019)

NLRC5 Might Promote Endometrial Cancer Progression by Inducing PD-L1 Expression
por: Zhu, Su-ding, et al.
Publicado: (2022)

Emerging Roles for NLRC5 in Immune Diseases
por: Wang, Jie-quan, et al.
Publicado: (2019)

NLRC5/CITA expression correlates with efficient response to checkpoint blockade immunotherapy
por: Yoshihama, Sayuri, et al.
Publicado: (2021)

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer
por: Kim, H, et al.
Publicado: (2001)

Expression and clinical value of NLRP1 and NLRC4 inflammasomes in prostate cancer
por: Liang, Ke, et al.
Publicado: (2023)

High Expression of SQSTM1/p62 Protein Is Associated with Poor Prognosis in Epithelial Ovarian Cancer
por: Iwadate, Reiko, et al.
Publicado: (2014)

The expression of NOD2, NLRP3 and NLRC5 and renal injury in anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Wang, Luo-Yi, et al.
Publicado: (2019)

Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer
por: Maehara, Y, et al.
Publicado: (2000)

NLRC5: A Potential Target for Central Nervous System Disorders
por: Zhang, Lu, et al.
Publicado: (2021)

NLRC5, a promising new entry in tumor immunology
por: Chelbi, Sonia T., et al.
Publicado: (2016)

NLRC5-CIITA Fusion Protein as an Effective Inducer of MHC-I Expression and Antitumor Immunity
por: Santharam, Madanraj Appiya, et al.
Publicado: (2023)

Obesity-associated NLRC4 inflammasome activation drives breast cancer progression
por: Kolb, Ryan, et al.
Publicado: (2016)

Inhibition of NLRC5 attenuates the malignant growth and enhances the sensitivity of gastric cancer cells to 5-FU chemotherapy by blocking the carcinogenic effect of YY1
por: Liang, Shan, et al.
Publicado: (2022)

NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers
por: Ong, Chrissie E. B., et al.
Publicado: (2021)

Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases
por: Correa, Ricardo G., et al.
Publicado: (2012)

Involvement of the NLRC4-Inflammasome in Diabetic Nephropathy
por: Yuan, Fang, et al.
Publicado: (2016)

High expression of ceramide synthase 5 predicts a poor prognosis in gastric cancer
por: Zhang, Shengjie, et al.
Publicado: (2022)

Association of Tim-3/Gal-9 Axis with NLRC4 Inflammasome in Glioma Malignancy: Tim-3/Gal-9 Induce the NLRC4 Inflammasome
por: Sim, JeongMin, et al.
Publicado: (2022)

NLRC5, a valuable marker for the diagnosis and prognostic assessment of hepatocellular carcinoma
por: Zhang, Xiu-Wen, et al.
Publicado: (2020)

Associations between NLRC4 Gene Polymorphisms and Autoimmune Thyroid Disease
por: Liu, Xuerong, et al.
Publicado: (2020)

Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer
por: Ebert, M P A, et al.
Publicado: (2000)

Methylation of the genes ROD1, NLRC5, and HKR1 is associated with aging in Hainan centenarians
por: Zeng, Qian, et al.
Publicado: (2018)

Distinct Expression and Prognostic Value of MS4A in Gastric Cancer
por: Sun, Lei, et al.
Publicado: (2018)

NLRC4 and TLR5 Each Contribute to Host Defense in Respiratory Melioidosis
por: West, T. Eoin, et al.
Publicado: (2014)

Transcriptional Upregulation of NLRC5 by Radiation Drives STING- and Interferon-Independent MHC-I Expression on Cancer Cells and T Cell Cytotoxicity
por: Zebertavage, Lauren K., et al.
Publicado: (2020)

High Hepsin expression predicts poor prognosis in Gastric Cancer
por: Zhang, Mingming, et al.
Publicado: (2016)

High tPA-expression in primary melanoma of the limb correlates with good prognosis
por: Ferrier, C M, et al.
Publicado: (2000)

Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate
por: Setälä, L P, et al.
Publicado: (1999)

A Study of NLRC4 in Patients with Leprosy
por: Batta, Salma Mosaad, et al.
Publicado: (2023)

The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy
por: Shukla, Akhil, et al.
Publicado: (2021)

High expression of VCAN is an independent predictor of poor prognosis in gastric cancer
por: Li, Wenfei, et al.
Publicado: (2020)

Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection
por: Choi, J-H, et al.
Publicado: (2001)

NOD1, NOD2, and NLRC5 Receptors in Antiviral and Antimycobacterial Immunity
por: Godkowicz, Magdalena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r7kl2fbhfe0q69go56sqbo94gr